Efficacy of cryobiopsy during medical thoracoscopy for diagnosing malignant pleural mesothelioma

April 2, 2025 | Comments Off on Efficacy of cryobiopsy during medical thoracoscopy for diagnosing malignant pleural mesothelioma

Lung Cancer 2025 January [Link] Hayato Nanami, Yuji Matsumoto, Hideaki Furuse, Midori Tanaka, Takaaki Tsuchida, Yuichiro Ohe Abstract Objectives: Malignant pleural mesothelioma (MPM) is difficult to differentiate from other pleural…

Cytoreductive surgery in diffuse pleural mesothelioma. What have we learnt from MARS2, EORTC-L1205 and other recent studies?

April 1, 2025 | Comments Off on Cytoreductive surgery in diffuse pleural mesothelioma. What have we learnt from MARS2, EORTC-L1205 and other recent studies?

European Journal of Surgical Oncology 2925 January 21 [Link] Loïc Lang-Lazdunski Abstract Cytoreductive surgery remains controversial in pleural mesothelioma. The MARS2 trial suggested that extended pleurectomy decortication following neoadjuvant chemotherapy…

The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis

March 31, 2025 | Comments Off on The Effect of Systemic Inflammation and Clinicopathologic Features on Survival in Malignant Pleural Mesothelioma: A Multicenter Analysis

Medicina 2025 January 16 [Link] Nadiye Sever, Sedat Yıldırım, Ali Fuat Gurbuz, Delyadil Karakaş Kılıç, Esra Zeynelgil, Yunus Emre Altintaş, Berivan Deniz Çimik, Yeşim Ağyol, Ali Kaan Güren, Pınar Erel,…

Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma

March 28, 2025 | Comments Off on Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma

Marine Drugs 2025 January 10 [Link] Angélica Luna-Nophal, Fernando Díaz-Castillo, Vanessa Izquierdo-Sánchez, Jesús B Velázquez-Fernández, Mario Orozco-Morales, Luis Lara-Mejía, Johana Bernáldez-Sarabia, Noemí Sánchez-Campos, Oscar Arrieta, José Díaz-Chávez, Jorge-Ismael Castañeda-Sánchez, Alexei-Fedorovish…

Follow-up after first-Line nivOlumab plus ipilimumab in patients with diffuse pleuRal mesotheliomA: a real-world Dutch cohort study-FLORA

March 27, 2025 | Comments Off on Follow-up after first-Line nivOlumab plus ipilimumab in patients with diffuse pleuRal mesotheliomA: a real-world Dutch cohort study-FLORA

ESMO Open 2025 February [Link] L H Douma, M M Hofman, F Zwierenga, T M T Zondervan, A I G Buma, H Schouwink, D W Dumoulin, J A Burgers, I…

Recurrence Patterns and Management after Pleurectomy Decortication for Pleural Mesothelioma

March 26, 2025 | Comments Off on Recurrence Patterns and Management after Pleurectomy Decortication for Pleural Mesothelioma

Annals of Surgery 2025 January 15 [Link] Juuso Paajanen, William G Richards, Yue Xie, Emanuele Mazzola, Kristina Sidopoulos, John Kuckelman, Ritu R Gill, Raphael Bueno Abstract Objective: We hypothesize that…

A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial

March 25, 2025 | Comments Off on A randomised phase III study of bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial

Annals of Oncology 2025 January 13 [Link] E Felip, S Popat, U Dafni, K Ribi, A Pope, S Cedres, R Shah, F de Marinis, L Cove Smith, R Bernabé, M…

Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study

March 24, 2025 | Comments Off on Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1-Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study

JTO Clinical and Research Reports 2024 October 24 [Link] Prashasti Agrawal, Michael Offin, Victoria Lai, Michelle S Ginsberg, Prasad S Adusumilli, Valerie W Rusch, Jennifer L Sauter, Teresa Ho, Phillip…

Analysis of Pleiotropic Effects of Nivolumab in Patients with Relapsed Pleural Mesothelioma: A Single-Center Retrospective Study

March 21, 2025 | Comments Off on Analysis of Pleiotropic Effects of Nivolumab in Patients with Relapsed Pleural Mesothelioma: A Single-Center Retrospective Study

Oncology 2025 January 24 [Link] Tomoki Higashiyama, Kozo Kuribayashi, Hiroshi Doi, Aki Kubota, Taiichiro Otsuki, Yasuhiro Nakajima, Koji Mikami, Ryo Takahashi, Akifumi Nakamura, Daichi Fujimoto, Kazuhiro Kitajima, Toshiyuki Minami, Takashi…

Overcoming resistance to arginine deprivation therapy using GC7 in pleural mesothelioma

March 20, 2025 | Comments Off on Overcoming resistance to arginine deprivation therapy using GC7 in pleural mesothelioma

iScience 2024 December 2 [Link] Josephine Carpentier, Marta Freitas, Valle Morales, Katiuscia Bianchi, John Bomalaski, Peter Szlosarek, Sarah A Martin Abstract Pleural mesothelioma is a highly chemotherapy-resistant cancer. Approximately 50%…

Categories